Supernus Pharmaceuticals | SUPN - Attività Correnti





Attività Correnti Cambiamento Data
Abbott USD 25.51B 488M 2026-03
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 393.45M 4M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 506.36M 23.1M 2026-06
Cara Therapeutics USD 25.33M 6.21M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Novo Nordisk DKK 208.7B 31.38B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
United Therapeutics USD 3.48B 611.7M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06